|
V78751
|
Exatecan Intermediate 3
|
|
Exatecan Intermediate 3 is the intermediate of Exatecan. |
|
V76158
|
Izeltabart (IMGC-936)
|
2642078-60-0 |
Izeltabart (IMGC-936) is a Maytansinoid-based ADC targeting ADAM9. |
|
V53069
|
KRAS degrader-1
|
2795275-59-9 |
KRAS degrader-1 (compound 1) is a potent KRAS degrader. |
|
V88375
|
ORM-5029
|
|
ORM-5029 is the first antibody-drug conjugate (ADC) targeting human epidermal growth factor receptor 2 (HER2), which is a combination of the highly effective GSPT1 degrader SMol006 and Pertuzumab. |
|
V81404
|
SMP-33693
|
|
SMP-33693 is an Antibody-Drug Conjugates (ADCs) with a low payload shedding rate and has in vivo tumor inhibitory effects on ovarian cancer, gastric cancer, and breast cancer. |
|
V81405
|
SMP-88480
|
|
SMP-88480 is an Antibody-Drug Conjugates (ADCs). |
|
V81406
|
SMP-93566
|
|
SMP-93566 is an Antibody-Drug Conjugates (ADCs) with a low payload shedding rate and has in vivo tumor suppressive effects on ovarian cancer, gastric cancer, and breast cancer. |